XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Common Share And Share Awards Summary Of Share-Based Award Transactions (Details) - SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, SARS, Outstanding [Roll Forward]              
Number of shares, outstanding beginning balance   42   39 42 39  
Number of shares, SARs granted 5 0 4 1 5 5  
Number of shares, SARS exercised         (4) (2)  
Number of shares, SARS forfeited or expired         (4)    
Number of shares, outstanding ending balance         39 42 39
Number of shares, exercisable as of September 30, 2024         31    
Number of shares, unvested as of September 30, 2024         8    
Share-based Compensation Arrangement by Share-based Payment Award, SARs, Outstanding, Weighted Average Exercise Price [Roll Forward]              
Weighted average exercise price, outstanding beginning balance   $ 160.83   $ 159.39 $ 160.83 $ 159.39  
Weighted average exercise price, SARs granted         160.94 142.88  
Weighted average exercise price, SARS exercised         154.13 93.87  
Weighted average exercise price, forfeited or expired         192.71    
Weighted average exercise price, outstanding ending balance         157.74 $ 160.83 $ 159.39
Weighted average exercise price, exercisable as of September 30, 2024         159.86    
Weighted average exercise price, unvested as of September 30,2024         $ 148.86    
Average remaining contractual term, outstanding beginning balance         3 years 10 months 6 days 3 years 8 months 8 days 4 years 1 month 6 days
Average remaining contractual term, outstanding ending balance         3 years 10 months 6 days 3 years 8 months 8 days 4 years 1 month 6 days
Average remaining contractual term, exercisable as of September 30, 2024         3 years 7 months 9 days    
Average remaining contractual term, unvested as of September 30, 2024         4 years 9 months 29 days    
Aggregate intrinsic value, outstanding beginning balance   $ 428   $ 243 $ 428 $ 243  
Aggregate intrinsic value, outstanding ending balance         2,783 $ 428 $ 243
Aggregate intrinsic value, exercisable as of September 30, 2024         2,180    
Aggregate intrinsic value, unvested as of September 30, 2024         $ 603